Synopsis: As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its ...

By Kashish Tandon April 29 (Reuters) - India's Piramal Pharma hopes to accelerate earnings growth over the next two to three ...

Supply chain disruptions, higher energy and freight prices, and reliance on Chinese APIs are squeezing margins, raising the ...

Sun Pharma’s $11.75 billion acquisition of Organon marks a major global expansion, giving the Indian drugmaker scale in ...

Oct 31 (Reuters) - Medplus Health Services (MEDP.NS), opens new tab, one of India's top retail pharmacy chains, reported a 43.3% rise in second-quarter profit on Friday, driven by higher sales from ...

Sun Pharma to acquire Organon in a $12B deal, expanding global reach and strengthening its specialty drug portfolio.

Wegovy launched in India in 2025, but the patent on its core ingredient expires in the country this week India could soon get a lot thinner - at least in theory. On Friday the patent on semaglutide - ...

Jan 7 (Reuters) - Online pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, Ozempic, sourced from India to U.S. patients, as demand for ...

Prime Minister Narendra Modi on Tuesday said that India's pharma sector is moving up from the pharmacy of the world to a hub of innovation. Highlighting the country's growing focus on research-driven ...

Overview: Pharma funds can deliver high returns due to steady demand in healthcare.These funds carry high risk as they focus ...